Alternation of Epirubicin and Mitoxantrone in CHOP-like Regimens Retains Efficacy and Reduces Overall Toxicity in Elderly Patients with High and Intermediate Grade Non-Hodgkin Lymphomas-Reference-Cited by-同舟云学术

Alternation of Epirubicin and Mitoxantrone in CHOP-like Regimens Retains Efficacy and Reduces Overall Toxicity in Elderly Patients with High and Intermediate Grade Non-Hodgkin Lymphomas

Published:2002-01 Issue:12 Volume:43 Page:2319-2324
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Milone Giuseppe,Raimondo Francesco Di,Gioi Felicina Li,Palumbo Giuseppe A.,Manenti Giovanna Oriella,Pafumi Marzia,Giustolisi Rosario

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/1042819021000040026

Reference23 articles.

1. Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma.

2. Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing Age

3. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.

4. Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate-and high-grade non-Hodgkin's lymphomas

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Mucositis;Orofacial Supportive Care in Cancer;2022

2. Cardiovascular complications after radiotherapy;Cardiology Journal;2020-12-31

3. The Role of Echocardiography;Anti-Cancer Treatments and Cardiotoxicity;2017

4. Pericardial Effusion and Pericarditis;Anti-Cancer Treatments and Cardiotoxicity;2017

5. Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy;Cochrane Database of Systematic Reviews;2016-03-03